If Starpharma had any developments, they would have told us...

If Starpharma had any developments, they would have told us through a seperate ASX announcement so they could tout how wonderful they are in the bullet point section on the front page of the Quarterly like they always do ….. they obviously have nothing but we go through this every time in the lead up to a quarterly on here from some ?


At this stage it is looking like the bullet point section on page 1 will be tiny in the June Quarterly this week as we all know they achieved nothing of substance in that period - just some more DEP® irinotecan Phase 2 trial results that again failed to tantalise pharma groups or subsequently secure a DEP license deal ?


I would temper my expectations folks as SPL7013 revenues are likely to be disappointing also - just sayin’